Curriculum Vitae for David Scott Saperstein, M.D.

Education:

Undergraduate:
Boston University 1984-1988
Boston, MA
Degree: BA, Biology
Summa cum laude with distinction in Biology

Medical School:
Boston University School of Medicine 1988-1992
Boston, MA
Degree: MD

Postdoctoral Training:

Internal Medicine Residency:
Wilford Hall USAF Medical Center 1992-1994
San Antonio, TX

Neurology Residency:
Wilford Hall USAF Medical Center 1994-1997
San Antonio, TX

Neuromuscular Disease/Clinical Neurophysiology Fellowship:
University of Texas Southwestern Medical Center 1997-1998
Dallas, TX

Licensure

Arizona State Medical License # 34039 2005-present
Kansas State Medical License # 04-29601 2002-2005
Missouri State Medical License # 2002009374 2002-2005
Texas State Medical License # K4229 1997-2002
Pennsylvania State Medical License # MD-058627-L 1996
(inactive status 1999-present)                                                          

Board Certification:

American Board of Psychiatry and Neurology 1998
Certificate # 45963
Added Qualifications in Clinical Neurophysiology 2001
Certificate # 1301
American Board of Electrodiagnostic Medicine 2000
Certificate # 3047

Military Service:

U.S. Air Force, Active Duty 1992-2002
Honorable Discharge; rank of Major

Academic Appointments:

Current Academic Appointments:
Clinical Associate Professor 2006-present
Department of Neurology
University of Arizona
Phoenix, AZ

Previous Academic Appointments:
Assistant Professor 2002-2005
Department of Neurology
The University of Kansas Medical Center
Kansas City, KS

Assistant Professor (secondary appointment) 2002-2005
Department of Pathology and Laboratory Medicine
University of Kansas Medical Center
Kansas City, KS

Clinical Assistant Professor 1999-2002
Department of Medicine/Division of Neurology
University of Texas Health Science Center at San Antonio
San Antonio, TX

Positions Held:

Co-Director, Neuropathy Clinic 2007-present
Banner Good Samaritan Medical Center
Phoenix, AZ

Co-Director Neurodiagnostics Laboratory 2005-present
Banner Good Samaritan Medical Center
Phoenix, AZ

Chief, Neuromuscular Disease Service 2003-2005
Department of Neurology
The University of Kansas Medical Center
Kansas City, KS

Staff Neurologist 2002-present
Department of Neurology
The University of Kansas Medical Center
Kansas City, KS

Clerkship Director 2002-present
Department of Neurology
The University of Kansas Medical Center
Kansas City, KS

Chief of Neuromuscular Services, 1998-2002
Director of Electromyography Laboratory
Department of Neurology
Wilford Hall USAF Medical Center
San Antonio, TX

Staff Neurologist, Muscular Dystrophy Association Clinic 1999-2002
University of Texas Health Science Center at San Antonio
San Antonio, TX

Residency Training Officer 1999-2002
Department of Neurology
Wilford Hall USAF Medical Center
San Antonio, TX

Professional Memberships:

Society of Air Force Physicians 1992-2002
American Academy of Neurology 1994- present
American Association of Electrodiagnostic Medicine 1997- present
World Muscle Society 1999- present
Texas Neurological Society 2000- 2002
Peripheral Nerve Society 2003-present
Arizona Neurological Society 2005-present
Maricopa County Medical Society 2005-present

Committees:

National Committees:
Annual Meeting Workshop Committee 2003-2006
American Association of Electrodiagnostic Medicine

Chairman, Education Committee 2005-present
ALS Research Group

Member, AANEM Podcast Editorial Board 2006-present

Member, Medical Advisory Board 2007-present
Neuropathy Action Foundation

Local Committees:
Ad Hoc Committee on Medical Student Education 1999-2002
University of Texas Health Science Center at San Antonio

Medical Student Education Committee, Chairman 2002-present
Department of Neurology, KUMC

Research Committee 2002-present
Department of Neurology, KUMC

Curriculum Committee, Long-term Planning 2003-2004
University of Kansas School of Medicine

GCRC Planning Committee 2003-2004
University of Kansas Medical Center

Dean’s Pediatric Chair and Department Review Committee, 2004
Vice-Chairman
University of Kansas Medical Center

LCME Committee 2004-present
University of Kansas School of Medicine

Research Group Memberships:

Muscle Study Group 1998-present
Western ALS Study Group 1998-present
American ALS Research Group 2003-present
Northeast ALS Research Group 2005-present

Workshop Participation:

Bone Quality in Duchenne Muscular Dystrophy, July 8, 2004.
Sponsored by the Parent Project in Muscular Dystrophy.

Honors and Awards:

Boston University Trustee Scholar 1984-1988
Phi Beta Kappa Honor Society 1988
Alpha Omega Alpha Honor Society 1992
American Academy of Neurology Resident Teaching Award 1997
Neurophysiology Faculty Teaching Award, KUMC 2004, 2005

Grant Support:

Current Support:
Co-investigator (C. Odis, P.I.), Rituximab in Myositis. NIH. $140,000; 5/05-4/08.

Co-investigator (T. Levine, P.I.), Memantine in ALS. Forrest Pharmaceuticals. $125,000; 4/06-12/07.

Co-investigator (P. Gordan, P.I.), Selection Trial in ALS. NIH. $2189/patient; 7/06-6/07.

Principal Investigator, Database of Immune-Mediated Neuropathy Treatment Outcomes. Talecris Biotherapeutics. $75,550; 1/07-2/08.

Previous Support:
Co-investigator (R. Tawil, P.I.), Inclusion Body Myositis: A Pilot Study of Beta Interferon-1A. NIH (R01-NS38585-01). $37,500; 7/99–6/02.

Co-Investigator (Merit E. Cudkowicz MD, PI) A Clinical Trial of Celebrex in subjects with ALS. To determine if Celebrex slows down the progression of ALS. Funded by John Hopkins University via Muscular Dystrophy Association & Pharmacia Corp.

Co-Investigator (Jeffery Rosenfeld MD, PI) A Clinical Trial of Creatine in ALS. To determine if Creatine slow down the progression of ALS. Funded by FDA ODG # RO-1At00967-01A1

Co-Investigator (Donald B. Sanders, P.I) A Clinical Trial of Mycophenolate Mofetil in Myasthenia Gravis. To determine if Mycophenolate  slows down the progression of Myasthenia Gravis. Funded by FDA-OPD #FDA-R-002154, 4/1/2002 – 3/31/2005 and Roche Pharmaceutical Co. Grant CEL 248, 7/1/2002 – 6/30/2005.

Co-Investigator (Paul H. Gordon MD, PI) A Clinical Trial of Minocycline in subjects with ALS.  To determine if Minocycline slows down the progression of ALS.  Funded by NIH/NINDS # R01 NS045294-01

Co-investigator (Steven Greenberg MD, PI) Gene Expression in Inflammatory Myopathies study. To gain a better understanding of gene expression in various inflammatory myopathies. Funded by the National Institute of Health.  Funded by NINDS Grant # R01 NS043471-01A1  $2000/year; 12/1/02 – 11/30/05

Co-Investigator (supported trainee) (Robert Griggs MD, PI). Consortium in Neurologic Channelopathies (CINCH). To establish a network to study rare neurologic channelopathies. NIH/NCRR 1U54RR019482-01.

Co-Investigator (Rick T. Dobrowsky, Ph.D., PI) Proteomic approaches to diabetic neuropathy.  J.R. & Inez Jay Fund – University of Kansas

Co-investigator (Ellen Vernotica, Ph.D. Global Clinical Trial Leader) Study of TCH346 versus placebo for ALS. Novartis Pharmaceuticals. To determine if TCH346 can slow progression of ALS.

Co-Investigator (Carlayne Jackson MD, PI) A randomized, double-blind, placebo-controlled study of safety and efficacy of botulinum toxin type B (myobloc) for sialorrhea in amyotrophic lateral sclerosis.  To assess the benefit of botulinum toxin B in treated ALS-related silorrhea. Amyotrophic Lateral Sclerosis Association (ALSA).

Co-Investigator (Jeanne Drisko MD, PI) Intravenous glutathione for amyotrophic lateral sclerosis.  To determine if the antioxidant glutathione can significantly slow the progression of ALS. Private funding source.

Co-P.I. (Douglas Wright, Co-P.I.). Cutaneous innervation in human diabetic neuropathy. To study the role of different nerve fiber types in peripheral neuropathy pain. Leid Endowed Basic Science Pilot Research Grant. $35,000.

Co-Investigator. A randomized, double-blind, placebo controlled, dose-ranging study to determine the efficacy of Avonex when used in subjects with chronic inflammatory demyelinating polyneuropathy. To determine if Avonex therapy will allow IVIg to be discontinued. Biogen Protocol C-870.

Co-Investigator. A double-blind, placebo controlled, randomized, multiple ascending dose, safety study of MYO-029 administered to adult patients with Becker, facioscapulohumeral and limb-girdle muscular dystrophy. Wyeth Protocol # 3147K2-101-WW.

Clinical Research Studies:

Investigator for the following:
Biogen 101MS 402 for MS
Teva Bravo for MS
Lilly HMEF for MS
Merck Musi Qo1 for MS
Roche/Genentech olcrizimab for MS
Medimmune CP 151 for dermatomyositis/polymyositis
Cytex. Arimoclomol for ALS
Mass General. Ceftriaxone for ALS
T-GEN. Tretinoin for ALS
Schering-Plough TIMI 50 for post-stroke
Genzyme MTAP. Myozyme for Pompe
J&J 333369 NPP 2002 for diabetic peripheral neuropathy
Genentech. RIM study for dermatomyositis
Teva. ASSERT TNC GA for multiple sclerosis
Columbia University. Selection for ALS
Teva NABS PM 208 for multiple sclerosis
PalmMag Device for diabetic neuropathy
Biogen Stratta for multiple sclerosis
Lilly HMEZ for diabetic neuropathy
Lilly HMDY for diabetic neuropathy

Ad Hoc Reviewing:

Annals of Neurology   
Archives of Neurology             
Cochrane Reviews
Journal of the Peripheral Nervous System
Muscle & Nerve                       
Neurology       

Publications

Journal Publications:

1. Wolfe GI, Baker NS, Amato AA, Jackson CE, Nations SP, Saperstein DS, Cha C, Bryan WW, Barohn RJ. Cryptogenic sensory polyneuropathy: clinical and electrophysiologic characteristics. Arch Neurol 1999;56:540-547.
2. Saperstein DS, Amato AA, Wolfe GI, Katz JS, Nations SP, Bryan WW, Burns DK, Barohn RJ. Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome. Muscle Nerve 1999;22:560-566.
3. Katz JS, Wolfe GI, Andersson PB, Saperstein DS, Elliott JL, Nations SP, Bryan WW, Barohn RJ. Brachial amyotrophic diplegia: a slowly progressive motor neuron disorder. Neurology 1999;53:1071-1076.
4. Katz JS, Saperstein DS, Gronseth GS, Amato AA, Barohn RJ. Distal acquired demyelinating symmetrical neuropathy. Neurology 2000;54:615-620.
5. Saperstein DS, King RB. Motor neuron presentation of a deep ulnar branch neuropathy with a Riche-Cannieu anastomosis. Electromyogr Clin Neurophys 2000;40:119-122.
6. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve 2001;24:311-324.
7. KatzJS, Saperstein DS, Wolfe G, Nations SP, Alkhersam H, Amato AA, Barohn RJ. Cervicobrachial involvement in diabetic radiculoplexopathy. Muscle Nerve 2001;24:794-798.
8. Saperstein DS, Amato AA, Barohn RJ. Clinical and genetic aspects of distal myopathies. Muscle Nerve 2001;24:1440-1450.
9. Katz JS, Barohn RJ, Kojan S, Wolfe GI, Nations SP, Saperstein DS, Amato AA. Axonal multifocal motor neuropathy without conduction block or other features of demyelination. Neurology 2002;58:615-620.
10. Saperstein DS, Wolfe GI, Gronseth GS, Nations SP, Herbelin LL, Bryan WW, Barohn RJ. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch Neurol 2003;60:1296-301.
11. Katz JS, Rando TA, Barohn RJ, Saperstein DS, Jackson CE, Wicklund M, Amato AA. Late-onset distal muscular dystrophy affecting the posterior calves. Muscle Nerve 2003;28:443-448.
12. The Muscle Study Group (Tawil R, Griggs R, Thornton C, Kissel J, Mendell J, Genge A, Karpati G, Jackson C, Rose M, Amato A, Barohn R, Saperstein D). Randomized pilot trial of high-dose bINF-1a in patients with inclusion body myositis. Neurology 2004;63:718-720.
13. Sansone V, Saperstein DS, Barohn RJ, Meola G. Concurrence of facioscapulohumeral muscular dystrophy and myasthenia gravis. Muscle Nerve 2004;30:679-80. 
14. Grogan, PM, Tanner SM, Ørstavik KH, Saperstein DS, Vogel H, Barohn RJ, Herbelin LL, McVey AL, Katz JS. Limb girdle myopathy with skeletal asymmetry and hemidiaphragm elevation: mutations in the myotubularin gene causing a novel myopathy phenotype. Neurology 2005;64:1638-1640.
15. Gordon PH, Moore DH, Miller RG, and the Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 2007;6:1045-1053.

Editorials:

1. Yuki N, Saperstein DS. Axonal Guillain-Barre syndrome subtypes: Do we need more splitting? Neurology 2003;61:598-599.

Review Articles:

1. Barohn RJ, Saperstein DS. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1998;18:49-61.
2. Katz JS, Saperstein DS. Asymmetric acquired demyelinating polyneuropathies: MMN and MADSAM. Current Treatment Options in Neurology 2001;3:119-125.
3. Saperstein DS, Barohn RJ. Peripheral neuropathy due to cobalamin deficiency. Current Treatment Options in Neurology 2002;4:197-201.
4. SapersteinDS, Barohn RJ. Current concepts and controversy in chronic inflammatory demyelinating polyneuropathy. Current Neurology and Neuroscience Reports 2003;3:57–63.
5. Katz JS, Saperstein DS. Chronic Inflammatory Demyelinating Polyneuropathy. Curr Treat Options Neurol 2003;5:357-364.
6. Saperstein DS. Multifocal motor neuropathy: Diagnosis and treatment. Advances in Immunotherapy 2003;10:14-18.
7. Saperstein DS, Barohn RJ.  Management of myasthenia gravis. Semin Neurol 2004;24:41-48.
8. Saperstein DS. Chronic acquired demyelinating polyneuropathies. Semin Neurol 2008;28:168-184.
9. Saperstein DS. Muscle channelopathies. Semin Neurol 2008;28:260-269.

Abstracts:

1. Saperstein DS, King RB. Motor neuron presentation of a deep ulnar branch neuropathy with a Riche-Cannieu anastomosis. Muscle Nerve 1996;19:1200.
2. Saperstein DS, Gronseth GS. Cost-effectiveness analysis of echocardiography in stroke patients without cardiac risk factors. Neurology 1998;50 (Suppl 4):A446.
3. Iannaccone SI, Saperstein DS, Delgado M, Sparagana S. Childhood chronic inflammatory demyelinating polyneuropathy: clinical and laboratory features. Neurology 1998;50 (Suppl 4):A143-144.
4. Nations SP, Saperstein DS, Wolfe GI, Bryan WW, Barohn RJ. Clinical profile of vitamin B12 neuropathy. Neurology 1998;50 (Suppl 4):A208-209
5. Saperstein DS, Herbelin L, Bryan WW, Barohn RJ. 3,4-Diaminopyridine in the treatment of Lambert-Eaton Myasthenic Syndrome. J Child Neurol 1998;13:134-135.
6. Saperstein DS, Iannaccone SI, Brumback RA, Delgado M, Sparagana S. Relapsing acute Guillain-Barré syndrome: clinical, electrophysiologic and pathologic features. J Child Neurol 1998;13:136-137.
7. van der Sluis RW, Saperstein DS, Barohn RJ, Bryan WW. Chronic inflammatory demyelinating polyneuropathy in a patient with inherited demyelinating polyneuropathy. J Child Neurol 1998;13:137.
8. Saperstein DS, Amato AA, Katz JS, Wolfe GI, Nations SP, Jackson CE, Bryan WW, Barohn RJ. Multifocal sensory and motor neuropathy differs from multifocal motor neuropathy. Muscle Nerve 1998;21:1589.
9. Saperstein DS, Collins MP, Wolfe GI, Nations SP, Haller RG, Burns DK, Bryan WW, Barohn RJ. Hepatitis C virus infection and inflammatory myopathy. Neurology 1999;52 (Suppl 2):A451-A452.
10. Saperstein DS, Katz JS, Gronseth GS, Amato AA, Barohn RJ. Distal acquired demyelinating symmetric neuropathy and its distinction from CIDP. Neurology 2000;54 (Suppl 3):A384-A385.
11. Katz JS, Amato AA, Saperstein DS, Kojan S, Burns D, Nations S, Wolfe GI, Barohn RJ. Multifocal acquired axonal motor neuropathy. Neurology 2001;56(Suppl 3):A397.
12. Saperstein DS, Jackson CE, Nations SP, Wolfe GI, Barohn RJ. Uncommon neurologic manifestations of pernicious anemia with cobalamin deficiency. Neurology 2001;56(Suppl 3):A417.
13. Saperstein DS, Wolfe GI, Longeria O, Herbelin LL, Nations SP, Jackson CE, Bryan WW, Barohn RJ. Quantitative sensory testing in a large cohort of neuropathy patients. Muscle Nerve 2001;24:1417-1418.
14. Saperstein DS, Wolfe GI, Nations SP, Herbelin LL, Barohn RJ. Electrodiagnostic features of cobalamin deficiency polyneuropathy. Muscle Nerve 2002;26:574.
15. Marky B, Herbelin LL, Saperstein DS, Barohn RJ. Electrodiagnostic abnormalities in patients with syringomyelia. J Child Neurol 2003;18:212.
16. Barohn RJ, McVey AL, Herbelin LL, Saperstein D. Myotonic dystrophy and facioscapulohumeral muscular dystrophy in the same patient. J Child Neurol 2003;18:207.
17. Ali H, McVey AL, Saperstein DS, Herbelin L, Whitakker TJ, Fitzgerald K, Barohn RJ, So YT, Katz JS, Grogan PM. Bilateral optic nerve atrophy or papilledema with chronic inflammatory demyelinating polyneuropathy and serum paraprotein. J Child Neurol 2003;18:215.
18. Herbelin L, Lian G, Gronseth G, Wolfe G, Bryan W, Nations S, Saperstein D. Two point stimulation sensory conduction studies in normal nerves. Muscle Nerve 2003;Supplement 12:S69.
19. Saperstein DS, McVey AL, Herbelin LL, Newell K, Barohn RJ. Pain and weakness in a patient on a statin medication: It’s not always the statin. J Child Neurol 2004;19:204.
20. Herbelin L, Barohn RJ, McVey AL, Saperstein DS. A case of deep ulnar neuropathy at the wrist. J Child Neurol 2004;19:204.
21. Kumar S, Saperstein D, Herbelin L, Barohn RJ. Guillain-Barre syndrome in a patient with human erlichiosis infection. J Child Neurol 2004;19:206.
22. Wang Y. Barohn RJ, McVey AL, Newell K, Herbelin LL, Saperstein DS. Necrotizing myopathy: a unique immune-mediated myopathy. J Child Neurol 2004;19;207.
23. Saperstein DS, Grogan PM, Milford C, McVey AL, Wolfe GI, Nations SP, Herbelin LL, Barohn RJ, Skikne B, Vogel H, Katz JS. Myeloneuropathy in the setting of myelodysplastic syndrome. Neurology 2004;62(Suppl 5):A196.
24. Pasnoor M, McVey AL, Herbelin LL, Fishback JL, Barohn RJ, Saperstein DS. Anti-Hu antibodies and sensorimotor polyneuropathy associated with carcinoid tumorlet of lung. Ann Neurol 2004;56(Suppl 8):S60.
25. Herbelin LL, Drisko J, Barohn RJ, Saperstein DS, McVey AL, Khosh D, Dick A, Gronseth GS. Intravenous glutathione in ALS. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 2004;5(Suppl 2):117.
26. Alseoudi S, Anderson H, Herbelin L, Barohn RJ, McVey AL, Saperstein DS. Comparison of the Sensitivity of Diagnostic Criteria for Chronic Inflammatory Demyelinating Polyneuropathy.J Child Neurol 2005;20:271.
27. Barohn RJ, Saperstein DS, Herbelin , King W, McVey AL, Kissel J, Gronseth G, Mendell J. Open label study of etanercept for Inclusion body myositis. Neurology 2005;64(Suppl. 1):A158.
28. Bota DA, Gronseth G, Newell KL, Saperstein DS, McVey AL. Diagnostic Dilemma in a patient with the Heidenhain variant of Creutzfeldt-Jacob disease: case report and review of the literature. Neurology 2005;64(Suppl. 1):A251.
29. Barohn RJ, Rashid I, McVey AL, Herbelin L, Skikne B, Saperstein DS. Rituximab for the treatment of IgM-associated polyneuropathies. J Peripheral Nervous Sys 2005;10(Suppl.):4.
30. Saperstein DS, Grogan PM, Gronseth GS, Barohn RJ. The yield of routine laboratory tests in the evaluation of peripheral neuropathy patients in a general neurology setting. Neurology 2006;66(Suppl 2): A84.
31. Saperstein DS, Grogan PM, Gronseth GS, Wolfe GI, Nations SP, Barohn RJ. Comparison of causes for neuropathy observed in general and specialty clinics. Muscle Nerve 2006;34:517.
32. Saperstein DS, Alseoudi S, Anderson H, Herbelin L, McVey AL, Barohn RJ. The effect of combining clinical and electrodiagnostic data on the sensitivity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy (CIDP). J Peripher Nerv Syst 2007;12 (Suppl. 1):75-76.

Book Chapters:

1. Saperstein DS, Wolfe GI. Corticosteroid myopathies. In: Gilman S, Goldstein GW, Waxman SG, editors. Neurobase. San Diego: Arbor Publishing. Revised 1999-2006.
2. Saperstein DS, Wolfe GI. Myopathies associated with thyroid disease. In: Gilman S, Goldstein GW, Waxman SG, editors. Neurobase. San Diego: Arbor Publishing. Revised 1999-2006.
3. Barohn RJ, Saperstein DS. Acute and Chronic Inflammatory Demyelinating Polyneuropathy. In: Younger DS (ed.). Textbook of Motor Disorders. Philadelphia: Lippincott Williams & Wilkins 1999.
4. Saperstein DS. Inclusion Body Myositis. In: Gilman S, Goldstein GW, Waxman SG (eds.). Neurobase. San Diego: Arbor Publishing. Revised 2000-2007.
5. Saperstein DS. Viral and Retroviral Myositis. In: Gilman S, Goldstein GW, Waxman SG (eds.). Neurobase. San Diego: Arbor Publishing. Revised 2000-2007.
6. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Chronic Acquired Demyelinating Polyneuropathies. In: Sinha KK, Chandra P (eds.). Advances in Clinical Neurosciences 10. Ranchi, India: The Catholic Press; 2000: 187-206.
7. Saperstein DS, Amato AA, Katz JS, Barohn RJ. Immune Mediated Polyneuropathies.  In: Pourmand R (ed.). Neuromuscular Diseases: Expert Clinicians’ Views. Boston: Butterworth-Heinemann; 2001: 135-198.
8. Saperstein DS, Barohn RJ. Distal Myopathies. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro BE (eds.). Neuromuscular Disorders in Clinical Practice. Boston: Butterworth-Heinemann; 2002: 1092-1100.
9. Saperstein DS, Barohn RJ. Myasthenia Gravis. In: Rakel RE, Bope ET (eds.). Conn's Current Therapy.  Philadelphia: W.B. Saunders Company; 2002: 937-942.  
10. Saperstein DS. Distal myopathies. In: Gilman S, Goldstein GW, Waxman SG (eds.). Neurobase. San Diego: Arbor Publishing. Revised 2003-2006.
11. Saperstein DS, Barohn RB. Polyneuropathy due to nutritional and vitamin deficiency. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy, 4th ed. Philadelphia: Elsevier Saunders; 2005: 2051-2062.

Monographs:

1. Kissel JT, Amato AA, Barohn RJ, Iannaccone ST, Lange DJ, Mendell JR, Saperstein DS.  Muscle Disease. CONTINUUM: Lifelong Learning in Neurology, Volume 6. Philadelphia: Lippincott Williams & Wilkins; 2000.
2. Saperstein DS. Muscle Channelopathies. In: Amato AA (ed.), Muscle Diseases. CONTINUUM: Lifelong Learning in Neurology, Volume 12, Number 3. Philadelphia: Lippincott Williams & Wilkins; 2006.

Invited Lectures:

1. "Guillain-Barré Syndrome and Related Disorders." Guillain-Barré Syndrome Foundation International Support Group Meeting, San Antonio, TX, May 1, 1999.
2. "Demyelinating Neuropathies." Clinical Neurology Update 1999 (Army Medical Education Department), San Antonio, TX, November 17, 1999.
3. "The Dizzy Patient." 3rd Annual Fiesta CME Conference, Society of Air Force Physician Assistants, San Antonio, TX, November 2, 2000.
4. "Identifying The Treatable Neuropathy Patient." Clinical Neurology Update 2002 (Army Medical Education Department), San Antonio, TX, November 21, 2002.
5. "Diagnosis and Management of Hereditary Neuropathies." Neurology Grand Rounds, The University of Arizona Health Science Center, Tucson, AZ, October 29, 2004.
6. "Diagnosis and Classification of Hereditary Neuropathies." Neurology Grand Rounds, The Cleveland Clinic, Cleveland, OH, October 30, 2006.
7. "Long-Term Treatment of Chronic Inflammatory Demyelinating Polyneuropathy." Ninth Annual Symposium, GBS/CIDP Foundation International, Phoenix, AZ, November 3, 2006.
8. "Charcot-Marie-Tooth Disease." Muscular Dystrophy Association Patient Support Group Meeting, Dallas, TX, November 14, 2006.
9. "Diagnosis and Management of Hereditary Neuropathies." Neurology Grand Rounds, U.T. Southwestern Medical Center, Dallas, TX, November 15, 2006.

Course Instruction (National):

1. "Multifocal Motor Neuropathy." Course 1KP.002: The Spectrum of Chronic Demyelinating Polyneuropathy. 52nd Annual Meeting of the American Academy of Neurology, San Diego, CA, April 29, 2000.
2. "Multifocal Motor Neuropathy." Course 1KP.002: The Spectrum of Chronic Demyelinating Polyneuropathy. 53rd Annual Meeting of the American Academy of Neurology, Philadelphia, PA, May 5, 2001.
3. "Multifocal Motor Neuropathy." Course 2BS.008: The Spectrum of Chronic Demyelinating Polyneuropathy. 54th Annual Meeting of the American Academy of Neurology, Denver, CO,  April 14, 2002.
4. "Approach To The Patient With Muscle Cramps And Fatigue." Course 8AC.004: Clinical Approach to muscle Disease.  54th Annual Meeting of the American Academy of Neurology, Denver, CO,  April 20, 2002.
5. "CIDP and MADSAM" and "Pure Motor Neuropathies." Course 7DS.007: Common and Uncommon Phenotypes in Neuromuscular Disease. 55th Annual Meeting of the American Academy of Neurology, Honolulu, HI, April 4, 2003.
6. "Pure Motor Neuropathies." Course 2DS.008: Common and Uncommon Phenotypes in Neuromuscular Disease. 56th Annual Meeting of the American Academy of Neurology, San Francisco, CA, April 25, 2004.
7. "Cardiac, Pulmonary, and Muscle Complications of Myopathies." Course 8AC.002: Clinical Approach to Muscle Disease. 56th Annual Meeting of the American Academy of Neurology, San Francisco, CA, May 1, 2004.
8. "Outcome Measures in Clinical Neuromuscular Disease Trials." Course D: Clinical Research Design in Electrodiagnostic Medicine. 51st Annual Meeting of the American Association of Electrodiagnostic Medicine, Savannah, GA, November 4, 2004.
9. "Pure Lower Motor Neuron Syndromes." Course E: When It’s Not ALS! Pure Motor Syndromes. 51st Annual Meeting of the American Association of Electrodiagnostic Medicine, Savannah, GA, November 4, 2004.
10. Moderator: Biopsy and EMG Session, 27th Annual Carrel-Krusen Neuromuscular Symposium, Dallas, TX February 24, 2005.
11. Course Director, "Peripheral Neuropathy", 57th Annual Meeting of the American Academy of Neurology, Miami, FL, April 10, 2005.
12. "Selecting Laboratory Tests in the Peripheral Neuropathy Patient." Peripheral Neuropathy Course, 57th Annual Meeting of the American Academy of Neurology, Miami, FL, April 10, 2005.
13. "Numb Feet and Other Peripheral Neuropathy Presentations." Common and Uncommon Phenotypes in Neuromuscular Disease. 57th Annual Meeting of the American Academy of Neurology, Miami, FL, April 10, 2005.
14. "Numb Feet and Other Peripheral Neuropathy Presentations." Common and Uncommon Phenotypes in Neuromuscular Disease. 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, April 3, 2006.
15. Course Director, "Peripheral Neuropathy", 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, April 7, 2006.
16. "Selecting Laboratory Tests in the Peripheral Neuropathy Patient." Peripheral Neuropathy Course, 58th Annual Meeting of the American Academy of Neurology, San Diego, CA, April 7, 2006.
17. "Numb Feet and Other Peripheral Neuropathy Presentations." Course 2BS.004: "Common and Uncommon Phenotypes in Neuromuscular Disease", 59th Annual Meeting of the American Academy of Neurology, Boston, MA, April 29, 2007.
18. Course Director, Course 3FC.005: "Peripheral Neuropathy", 59th Annual Meeting of the American Academy of Neurology, Boston, MA, April 30, 2007.
19. "Chronic Acquired Demyelinating Polyneuropathies." Course 3FC.005: "Peripheral Neuropathy", 59th Annual Meeting of the American Academy of Neurology, Boston, MA, April 30, 2007.

Scientific Presentations: (no published abstract)

1. "Emery-Dreifus Myopathy: Clinical and Immunohistochemical Features."  20th Annual Carrell-Krusen Symposium, Texas Scottish Rite Hospital for Children, Dallas, TX, February 27, 1998.    
2. "Granulomatous Myositis in Association with Ovarian Cancer." Unusual Diagnostic and Management Problems in Neuromuscular Disease Seminar, 50th Annual Meeting of the American Academy of Neurology, Minneapolis, MN, May 1, 1998.
3. "A Case of Multifocal Acquired Demyelinating Sensory and Motor Neuropathy." Challenging EDX Cases Seminar, 45th Annual Meeting of the American Association of Electrodiagnostic Medicine, Orlando, FL, October 14, 1998.
4. "Nitrous Oxide-Induced Vitamin B12 Myeloneuropathy."  Unusual Diagnostic and Management Problems in Neuromuscular Disease Seminar, 52nd Annual Meeting of the American Academy of Neurology, San Diego, CA, May 1, 2000.
5. "Myopathy and Cramps in a Patient on a Statin Drug." Unusual Diagnostic and Management Problems in Neuromuscular Disease Seminar, 56th Annual Meeting of the American Academy of Neurology, San Francisco, CA, April 26, 2004.

Local Institution Talks:

1. "Multifocal Motor Neuropathy: Past, Present, and Future." Neurology Grand Rounds, University of Texas Health Science Center at San Antonio, December 10, 1999.
2. "Management of Patients Following TIA or Mild Stroke: Current Concepts and Controversies." Internal Medicine Grand Rounds, Wilford Hall Medical Center, March 12, 1999.
3. "Cost-Effectiveness Analysis of Echocardiography in Stroke Patients." Neurology Grand Rounds, University of Texas Health Science Center at San Antonio, June 24, 1999.
4. "Neuromuscular Pearls and Pitfalls."  Neurology Grand Rounds, University of Texas Health Science Center at San Antonio, January 20, 2000.
5. "The Peripheral Neuropathy Patient: What Tests to Order?" Neurology Grand Rounds, University of Texas Health Science Center at San Antonio, December 14, 2000.
6. "What Do You Do With An Elevated CK?" Neurology Grand Rounds, University of Texas Health Science Center at San Antonio, December 6, 2001.
7. "Identifying The Treatable Neuropathy Patient." Neurology Grand Rounds, University of Kansas Medical Center, December 13, 2002.
8. "The Patient with an Elevated CK." Neurology Grand Rounds, University of Kansas Medical Center, October 17, 2003.
9. "Neuropathy." Neurology Symposium 2007, Banner Good Samaritan Medical Center, Phoenix, AZ, April 13, 2007.